塞力医疗
(603716)
| 流通市值：48.00亿 | | | 总市值：48.00亿 |
| 流通股本：2.26亿 | | | 总股本：2.26亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 181,793,715.24 | 1,076,955,608.35 | 857,205,461.5 | 583,500,840.55 |
| 营业收入 | 181,793,715.24 | 1,076,955,608.35 | 857,205,461.5 | 583,500,840.55 |
| 二、营业总成本 | 195,176,452.61 | 1,168,127,783.62 | 925,431,549.78 | 631,911,725.44 |
| 营业成本 | 136,060,409.88 | 836,625,074.62 | 670,914,206.73 | 452,874,288.96 |
| 税金及附加 | 952,273.7 | 6,665,479.73 | 5,081,165 | 2,835,349.21 |
| 销售费用 | 16,994,101.66 | 91,528,753.04 | 71,467,670.26 | 47,023,885.66 |
| 管理费用 | 32,761,541.09 | 160,749,334.24 | 113,181,489.05 | 77,571,698.48 |
| 研发费用 | 6,509,264.3 | 41,775,859.02 | 29,804,720.56 | 24,527,034.96 |
| 财务费用 | 1,898,861.98 | 30,783,282.97 | 34,982,298.18 | 27,079,468.17 |
| 其中:利息费用 | 1,998,457.06 | 33,527,170.19 | 34,656,335.53 | 27,234,161.7 |
| 其中:利息收入 | 137,383.56 | 3,383,922.74 | 1,237,199.28 | 549,733.22 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -187,656.11 | 5,672,676.42 | 7,343,276.69 | 9,736,549.95 |
| 资产处置收益 | -182,010.54 | 248,367.57 | 880,251.38 | 835,879.46 |
| 资产减值损失(新) | -458,284.86 | -53,947,696.8 | -760,803.78 | -372,558.04 |
| 信用减值损失(新) | -6,003,661.02 | -10,242,488.96 | -20,713,016.78 | -14,002,932.83 |
| 其他收益 | 290,828.84 | 2,351,291 | 993,212.15 | 952,316.55 |
| 四、营业利润 | -19,923,521.06 | -147,090,026.04 | -80,483,168.62 | -51,261,629.8 |
| 加:营业外收入 | 199,919.7 | 1,182,542.52 | 917,795 | 72,326.36 |
| 减:营业外支出 | 23,983.2 | 6,455,604.89 | 793,402.93 | 736,808.08 |
| 五、利润总额 | -19,747,584.56 | -152,363,088.41 | -80,358,776.55 | -51,926,111.52 |
| 减:所得税费用 | -2,525,091.22 | 49,079,488.13 | -1,205,573.22 | -372,487.66 |
| 六、净利润 | -17,222,493.34 | -201,442,576.54 | -79,153,203.33 | -51,553,623.86 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -17,222,493.34 | -201,442,576.54 | -79,153,203.33 | -51,553,623.86 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -17,519,172.08 | -207,283,948 | -87,244,076.83 | -56,119,215.09 |
| 少数股东损益 | 296,678.74 | 5,841,371.46 | 8,090,873.5 | 4,565,591.23 |
| 扣除非经常损益后的净利润 | -17,708,792.54 | -218,908,801.85 | -102,543,073.87 | -70,597,925.09 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.08 | -1.04 | -0.44 | -0.29 |
| (二)稀释每股收益 | -0.08 | -1.04 | -0.44 | -0.29 |
| 八、其他综合收益 | -49,986.53 | -33,894,023.93 | -1,253,927.2 | -700,021.85 |
| 归属于母公司股东的其他综合收益 | -49,986.53 | -33,894,023.93 | -1,253,927.2 | -700,021.85 |
| 九、综合收益总额 | -17,272,479.87 | -235,336,600.47 | -80,407,130.53 | -52,253,645.71 |
| 归属于母公司股东的综合收益总额 | -17,569,158.61 | -241,177,971.93 | -88,498,004.03 | -56,819,236.94 |
| 归属于少数股东的综合收益总额 | 296,678.74 | 5,841,371.46 | 8,090,873.5 | 4,565,591.23 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |